The Brandologist™
Industry Guides

The Numbers Nobody Talks About

The product development side of launching a skincare brand gets a lot of airtime. The commercial reality — what things actually cost to produce, what margins look like, what wholesale does to your business model, and how long until you break even — gets significantly less. This is the post that fixes that.

Kate Edwards
Kate Edwards
February 18, 2026

Why This Conversation Gets Avoided

Nobody launching a skincare brand wants to lead with spreadsheets. The energy is in the product, the brand, the vision. The commercial mechanics feel like a problem for later — something to figure out once the product exists and the sales start coming in.

That sequencing is one of the most reliable ways to build a brand that works creatively and fails commercially.

The brands that survive past year two are the ones where the founder understood the numbers before they committed to a price point, a channel strategy, or a minimum order quantity. The ones that don't are usually surprised — not by one catastrophic decision, but by a slow accumulation of margin erosion they didn't see coming because they never modelled it.

This is the commercial reality of skincare. Not to discourage you from it — but to make sure you go in knowing what you're actually working with.

Cost of Goods Sold — The Number That Drives Everything

COGS is the total cost to produce one unit of your product, ready for sale. It is not just the cost of the formula. It is every input that goes into that unit landing in your hand.

For a skincare product, COGS typically includes: the formula itself (cost per unit at your MOQ), primary packaging (bottle, jar, tube, pump, cap), secondary packaging (box, sleeve, insert), labels (printed and applied, or label stock if self-applying), batch testing (if amortised per unit), and freight from manufacturer to your door or your 3PL.

At small MOQs — which is where most independent brands start — COGS per unit is high. The formula cost per unit at 500 units is not the same as at 5,000 units. The packaging cost per unit on a run of 500 custom boxes is not the same as at 2,500. Every input has a volume curve, and at low volumes, every one of those curves is working against you.

A realistic COGS for a mid-range skincare product at initial MOQ — not a budget product, not a luxury one — is typically between $8 and $20 AUD per unit depending on formula complexity, packaging spec, and volume. Premium positioning with genuinely differentiated ingredients or packaging can push that significantly higher. Private label with stock packaging at the lower end of the range can be tighter.

Know your number before you set your retail price. Not after.

Margins — What You Actually Keep

Retail price minus COGS is gross margin. It sounds simple. It is, until you account for everything that comes out of it before it resembles profit.

For direct-to-consumer sales, a healthy gross margin for a skincare brand is generally 65-75%. That means a product with $10 AUD COGS should retail somewhere between $28 and $40 AUD to hit that range. Lower margins than that, and the business model becomes very difficult to sustain once you factor in marketing costs, fulfilment, platform fees, and returns.

Wholesale changes the picture materially. Standard wholesale in Australia is 50% of RRP. That means if your product retails for $40 AUD, you're selling to stockists at $20 AUD. With a $10 COGS, your gross margin on that wholesale unit is $10 — half what it was on a DTC sale. If freight, fulfilment, and sales rep costs come out of that, the number shrinks further.

Pharmacy and independent retailer margins can vary. Consignment arrangements — where you don't get paid until the product sells — put all the inventory risk on you. Promotional requirements, ranging fees, and co-op marketing contributions exist in some retail channels and are not always disclosed upfront.

None of this means wholesale is the wrong strategy. It means wholesale requires a retail price and COGS structure that can absorb it without killing the business. Work backwards from the channel before you commit to the price.

Cash Flow — The Gap That Catches Brands Off Guard

Gross margin is not cash flow. The gap between them is where a lot of otherwise viable skincare brands run into serious trouble.

The core cash flow problem in product-based businesses is timing. You pay for stock before it sells. At small MOQs with overseas manufacturing, you may be paying for product three to four months before it's in your hands, and another month or two before enough of it has sold to cover the outlay. In that window, you still have operating costs. Marketing spend. Website maintenance. Contractor fees. Storage and fulfilment costs.

Reorder timing compounds this. If your first run sells through faster than expected — which sounds like a good problem — and you haven't already placed the next order, you're out of stock while waiting for the next production run. Stock-outs cost you sales, momentum, and in some cases retail ranging. If you've reordered early to avoid that, you've committed capital before the previous run has paid for itself.

The brands that navigate this well are the ones who modelled cash flow before launch — not just projected revenue, but the actual timing of when money goes out and when it comes back in, across realistic sales scenarios rather than optimistic ones.

Break-Even — When Does This Actually Make Money?

Break-even is the point at which total revenue covers total costs — COGS plus all fixed and variable operating expenses. For most independent skincare brands, it is further away than the initial projection suggests.

The reason is usually marketing costs, which are chronically underestimated in early financial models. Acquiring a new customer costs money. In a category as competitive as skincare, it costs more than founders typically budget for. If your customer acquisition cost is $30 AUD and your gross margin per unit is $20 AUD, you are losing money on every first purchase. The business model only works if that customer comes back — and building the retention strategy to make that happen is its own investment.

Break-even for a bootstrapped skincare brand doing this properly — accounting for actual marketing spend, operating costs, and realistic sales velocity rather than best-case projections — is often 18 to 24 months from launch. Some brands get there faster. Some take longer. The ones that get there faster are usually the ones who modelled it honestly from the start and made channel, pricing, and marketing decisions that were coherent with the number.

There's no right or wrong answer on when you break even. There's only whether your plan is realistic, and whether you have enough runway to get there.

The Model Has to Work Before You Launch

Commercial viability is not something to figure out once the brand is live and the product is on shelves. By that point, the key decisions — price point, channel mix, MOQ, packaging spec — are already locked in, and changing them is expensive and disruptive.

The brands with staying power are the ones where the founder stress-tested the model before committing to it. Where the pricing reflected the COGS and the channel strategy. Where the cash flow projection was honest about timing. Where break-even was a real number based on real costs, not a rough guess attached to an optimistic sales forecast.

If you're building the commercial model for your brand and want a second set of eyes on whether the numbers actually work — that's a conversation worth having before launch, not after.